Equitable Trust’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.98M | Sell |
49,705
-405
| -0.8% | -$46.8K | 0.28% | 73 |
|
|
2025
Q4 | $5.27M | Sell |
50,110
-1,325
| -3% | -$124K | 0.24% | 84 |
|
|
2025
Q3 | $4.32M | Sell |
51,435
-971
| -2% | -$80K | 0.2% | 96 |
|
|
2025
Q2 | $4.15M | Sell |
52,406
-1,576
| -3% | -$125K | 0.21% | 90 |
|
|
2025
Q1 | $4.85M | Sell |
53,982
-2,321
| -4% | -$217K | 0.27% | 72 |
|
|
2024
Q4 | $5.6M | Sell |
56,303
-2,307
| -4% | -$238K | 0.31% | 62 |
|
|
2024
Q3 | $6.66M | Buy |
58,610
+3,015
| +5% | +$358K | 0.43% | 47 |
|
|
2024
Q2 | $6.88M | Buy |
55,595
+1,290
| +2% | +$166K | 0.47% | 44 |
|
|
2024
Q1 | $7.17M | Sell |
54,305
-2,483
| -4% | -$306K | 0.5% | 41 |
|
|
2023
Q4 | $6.19M | Hold |
56,788
| – | – | 0.47% | 43 |
|
|
2023
Q3 | $5.85M | Buy |
56,788
+118
| +0.2% | +$12.7K | 0.48% | 43 |
|
|
2023
Q2 | $6.54M | Hold |
56,670
| – | – | 0.5% | 39 |
|
|
2023
Q1 | $6.03M | Sell |
56,670
-1,869
| -3% | -$202K | 0.47% | 41 |
|
|
2022
Q4 | $6.49M | Sell |
58,539
-781
| -1% | -$79.8K | 0.51% | 39 |
|
|
2022
Q3 | $5.11M | Buy |
59,320
+705
| +1% | +$62.9K | 0.43% | 51 |
|
|
2022
Q2 | $5.34M | Buy |
58,615
+2,704
| +5% | +$240K | 0.4% | 57 |
|
|
2022
Q1 | $4.59M | Buy |
55,911
+4,655
| +9% | +$367K | 0.29% | 80 |
|
|
2021
Q4 | $3.93M | Sell |
51,256
-26,983
| -34% | -$2.15M | 0.24% | 99 |
|
|
2021
Q3 | $5.88M | Sell |
78,239
-476
| -0.6% | -$36.2K | 0.38% | 70 |
|
|
2021
Q2 | $6.12M | Sell |
78,715
-8,191
| -9% | -$609K | 0.39% | 64 |
|
|
2021
Q1 | $6.39M | Sell |
86,906
-4,073
| -4% | -$300K | 0.48% | 60 |
|
|
2020
Q4 | $7.1M | Buy |
90,979
+703
| +0.8% | +$53.8K | 0.53% | 55 |
|
|
2020
Q3 | $7.15M | Buy |
90,276
+122
| +0.1% | +$9.56K | 0.61% | 48 |
|
|
2020
Q2 | $6.65M | Sell |
90,154
-194
| -0.2% | -$14.6K | 0.61% | 49 |
|
|
2020
Q1 | $6.63M | Sell |
90,348
-888
| -1% | -$69.8K | 0.73% | 38 |
|
|
2019
Q4 | $7.92M | Sell |
91,236
-523
| -0.6% | -$43K | 0.77% | 34 |
|
|
2019
Q3 | $7.37M | Buy |
91,759
+2,338
| +3% | +$187K | 0.78% | 35 |
|
|
2019
Q2 | $7.16M | Buy |
89,421
+1,536
| +2% | +$118K | 0.76% | 34 |
|
|
2019
Q1 | $6.97M | Sell |
87,885
-3,352
| -4% | -$251K | 0.81% | 33 |
|
|
2018
Q4 | $6.65M | Buy |
91,237
+191
| +0.2% | +$13.5K | 0.88% | 31 |
|
|
2018
Q3 | $6.16M | Sell |
91,046
-4,938
| -5% | -$315K | 0.72% | 38 |
|
|
2018
Q2 | $5.56M | Buy |
+95,984
| New | +$5.42M | 0.7% | 39 |
|
Other funds holding MRK
VCM
VPM
Equitable Trust's MRK Position: Q1 2026 in Review
Equitable Trust reduced its Merck (MRK) stake by 0.81% in Q1 2026, selling an estimated $46.8K and leaving 49,705 shares worth $5.98M. The position accounts for 0.28% of the portfolio, ranked #73.
Equitable Trust first reported a position in MRK in Q2 2018 and has held it in 32 quarters since. The position peaked at $7.92M in Q4 2019. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Equitable Trust held 49,705 shares of Merck worth $5.98M as of Q1 2026.
- Equitable Trust sold 405 Merck shares in Q1 2026, an estimated $46.8K.
- Merck made up 0.28% of Equitable Trust's portfolio in Q1 2026, its #73 holding.
- Equitable Trust first reported a position in Merck in Q2 2018 and has held it in 32 quarters since.
- Equitable Trust's Merck position peaked at $7.92M in Q4 2019.
- 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Equitable Trust's 13F filing for Q1 2026, filed 30 Apr 2026.